Integrity Coronary Stent System    

ACS & AMI
Angiomyogenesis & Cell Therapy
Carotid Interventions
Imaging
Complex Coronary Interventions
Chronic Total Occlusion
Drug-Eluting Stents
Emerging Devices & Innovative Therapies
Nurse & Tech Corner
Peripheral Interventions
Vulnerable Plaque
Workshop with the FDA


 Interventional Cardiology -> Abstracts

4/18/2006
Plaque Gruel of Atheromatous Coronary Lesion May Contribute to the No-Reflow Phenomenon in Patients With Acute Coronary Syndrome
Jun-ichi Kotani, Shinsuke Nanto, Gary S. Mintz, Masafumi Kitakaze, Tomoki Ohara, Takakazu Morozumi, Seiki Nagata, Masatsugu Hori

4/18/2006
Intracoronary Thrombectomy With the X-Sizer Catheter System Improves Epicardial Flow and Accelerates ST-Segment Resolution in Patients With Acute Coronary Syndrome: A Prospective, Randomized, Controlled Study
Gilbert Beran, MD et al

4/18/2006
Plaque Gruel of Atheromatous Coronary Lesion May Contribute to the No-Reflow Phenomenon in Patients With Acute Coronary Syndrome
Jun-ichi Kotani, Shinsuke Nanto, Gary S. Mintz, Masafumi Kitakaze, Tomoki Ohara, Takakazu Morozumi, Seiki Nagata, Masatsugu Hori

4/18/2006
Intravascular Ultrasound Findings in the Multicenter, Randomized, Double-Blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) Trial
Patrick W. Serruys, et al

4/18/2006
Stroke Complicating Percutaneous Coronary Interventions Incidence, Predictors, and Prognostic Implications
Shmuel Fuchs, MD; Eugenio Stabile, MD; Timothy D. Kinnaird, MD; Gary S. Mintz, MD; Luis Gruberg, MD; Daniel A. Canos, MPH; Ellen E. Pinnow, MS; Ran Kornowski, MD; William O. Suddath, MD; Lowell F. Satler, MD; Augusto D. Pichard, MD; Kenneth M. Kent, MD; Neil J. Weissman, MD

4/18/2006
In-stent restenosis in small coronary arteries: Impact of strut thickness
Carlo Briguori

4/18/2006
First Clinical Experience With a Paclitaxel Derivate–Eluting Polymer Stent System Implantation for In-Stent Restenosis: Immediate and Long-Term Clinical and Angiographic Outcome
Francesco Liistro, MD et al

4/18/2006
Twelve Versus Six Months of Clopidogrel to Reduce Major Cardiac Events in Patients Undergoing -Radiation Therapy for In-Stent Restenosis Washington Radiation for In-Stent restenosis Trial (WRIST) 12 Versus WRIST PLUS
Ron Waksman, MD; Andrew E. Ajani, MD; Ellen Pinnow, MS; Edouard Cheneau, MD; Laurent Leborgne, MD; Regina Dieble, RN; Anh B. Bui, MD; Lowell F. Satler, MD; Augusto D. Pichard, MD; Kenneth K. Kent, MD; Joseph Lindsay, MD

4/14/2006
Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts
Waksman R, et al

Interventional Cardiology -> Slide Presentations

5/11/2006
Diabetes and Coronary Artery Disease
Robert Frye, MD

5/11/2006
SIRIUS and TAXUS II
Lowell Satler

4/19/2006
Lessons from the RAVEL Study
Morice

4/19/2006
Clinical and Angiographic Outcomes After Use of Sr-90
Jeffrey J. Popma

4/19/2006
Conflict of Interest and Financial Disclosure
Daniel C. Adelman, MD

4/19/2006
TAXOL Program for In-Stent Restenosis
Ivan De Scheerder

4/19/2006
An Advanced c-myc Antisense for Prevention of Restenosis
Nicholas Kipshidze M.D.

4/19/2006
Research 2002: Who is at Risk, The Patient or Me?
Daniel L. Herr M.D.

4/19/2006
Clinical Studies of Jomed Graft Stents
Morice

4/19/2006
TAXUS Paclitaxel Eluting Stent Program from Bench to Bedside
Mary E. Russell, M.D.

4/19/2006
Major Complications of Complex PCI
John S. Douglas Jr. M.D.

4/19/2006
Current State of the PLLA Biodegradable Stent
Hideo Tamai, M.D.

4/19/2006
Statin-Mediated Regulation of Vessel Function
Kenneth Walsh, Ph.D.

4/18/2006
Why I Am Not a Believer in Drug-Eluting Stents
Julio C Palmaz,MD

4/18/2006
PCI and Pharmacologic Therapy for Acute MI and ACS.ppt
Peter Berger, MD

4/18/2006
Drug-Eluting Stents: Establishing Standard Methods
Robert S. Schwartz, MD

4/18/2006
Heparin Coated Stents
David O. Williams, M.D.

4/18/2006
Biocompatibles Phosphorylcholine Coated Stent Program
Jeffrey Popma, MD

4/18/2006
The ORBIT Trial
Waksman

4/18/2006
Cellular Effects of Intracoronary PhotoPoint PDT
Waksman

4/18/2006
An Assesment of Restenosis on the Eve of Drug-Eluting Stents
James P. Zidar, M.D.

4/18/2006
What Else Can we Learn From the CABG PTCA Trials?
Spencer B. King, III, MD

4/18/2006
PFO Closure Devices
Michael C. Slack, MD

4/18/2006
State of the Art Management of Acute MI
Gregg W. Stone, MD

4/18/2006
CREDO
Peter B. Berger, MD

4/18/2006
Antiplatelet Management for PCI Patients
Peter B. Berger, MD

4/18/2006
Which Heparin Should We Use for PCI?
Jonathan D. Marmur, MD

4/18/2006
Pharmacology Update: Heparin Is Not Enough
Sue Apple, DNSc, RN, CCRN

4/18/2006
Vascular Closure Devices
Kelly McNeil-Jones, RN, BSN, RCIS

4/18/2006
Management of SVGs
John S. Douglas, Jr., MD

4/18/2006
Laser Angioplasty for Acute MI
On Topaz, MD

4/18/2006
Total Occlusion Devices
Charles Simonton, MD

4/18/2006
The Use of Ablative Devices in 2003
William O. Suddath, MD

4/18/2006
Devices for PCI Beyond Drug Eluting Stents?
Charles Simonton, MD

4/18/2006
Moderate Sedation: Is Your Lab Up-to-Date?
Dina L. Rosenthal, RN, BSN, CCRN

4/18/2006
Informed Consent in the Catheterization Lab
Daniel L. Herr, MD

4/18/2006
A Brief Look at the History of Interventional Cardiology
Kenneth M. Kent, MD

4/18/2006
Controversies in Optimal Antiplatelet Therapy
Christopher Cannon, MD

4/18/2006
Diabetes
Robert Frye, MD

4/18/2006
Post PCI Management
Lowell Satler, MD

4/18/2006
The Future of Interventional Cardiology
David R. Holmes, Jr., MD

4/18/2006
Stent Design Matters...All Stents Are Not Created Equal
Helmut Schuhlen, MD

4/18/2006
What is the Optimal Antiplatelet Regimen in PCI Patients?
Steven R. Steinhubl, MD

4/18/2006
Beyond the Coronary Artery: The Next Generation of Endovascular Therapy
Craig Alan Thompson, MD

4/18/2006
Anti-Thrombotic Therapy in PCI
James Tcheng, MD

4/18/2006
PFO and Left Atrial Appendage Device
Bernhard Meier, MD

4/18/2006
How do all These New Toys Impact Patient Care?
Dina L. Rosenthal, RN, BSN, CCRN

4/18/2006
Thoracic Stents
Debra L. Dewald, RCIS

4/18/2006
Percutaneous Mitral Valve Repair
Kenneth M. Kent, M. D.

4/18/2006
Virtual Histology: Ready for Prime Time?
James R. Margolis, MD

4/18/2006
PFO/ ASD Strategies, Treatment
Michael C. Slack, MD

4/18/2006
Why and When to Use Low Molecular Weight Heparin
Dean Kereiakes, MD

4/18/2006
Alcohol Septal Ablation
Kenneth M. Kent, MD

4/18/2006
Virtual Histology: Ready for Prime Time?
J.J.R.M. (Hans) Bonnier, MD

4/18/2006
Changes in Strategy: Real World DES
Alexandre Abizaid, MD, PhD

4/17/2006
Distal Protection Devices
John S. Douglas, MD

4/17/2006
Post Intervention Medical Management
Spencer B. King, III, MD

4/17/2006
Thrombectomy Devices
Richard E. Kuntz, M.D., M.Sc.

4/17/2006
What's New for SVG?
John S. Douglas, Jr., MD

4/17/2006
Chronic Total Occlusion
Charles Simonton, MD

Interventional Cardiology -> Coronary Devices

Interventional Cardiology -> Coronary Lesions

6/20/2006
Additional Value of NIR Stent in Treating Long Lesions

6/20/2006
Impact of the Number of Stents on Restenosis

6/20/2006
The Challenge of Ostial In-Stent Restenosis with Intracoronary Radiation
Ajani et al.

6/20/2006
Three Strategies for the Treatment of Aorto Ostial Disease: Early and Late Results
Abizaid et al.

6/20/2006
Aroto Ostial Disease

Interventional Cardiology -> Patient SubSets

Interventional Cardiology -> Clinical Trials































ACS & AMI
Angiomyogenesis & Cell Therapy
Carotid Interventions

Home | CRT2013 | CardioTube | Interesting Cases | Trials | Weekly Poll Archive | Newsletter Archive | Login


Copyright © 2014, CRTONLINE - About / Contact Us. All rights reserved. Privacy Policy
Powered by Multiweb